Capricorn Partners
Leuven, Flemish Brabant, BEBelgiumFounded 1993
Leuven, Flemish Brabant, BEBelgiumFounded 1993
Capricorn Industrial Biotech Fund targets investments in nutritional ingredients, fibers and textiles, personal care, chemicals, and industry enablers.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.
Top Investment Stages
Technology Impact Funds is a fund family managed by Capricorn Investment Group. It invests in companies whose products and services address environmental and social challenges.
NCIC Tech Fund I is the equity vehicle of New Canaan Impact Capital, a merchant bank in Spartanburg, South Carolina that invests directly and syndicates through broker-dealer partner Carofin. The fund backs innovations addressing real-world challenges, with a stated emphasis on intellectual property, and applies an industry-agnostic screen.
Vesalius Biocapital III invests in European life sciences companies developing medicines, medical devices, diagnostics, and digital health technologies. The fund backs science-based innovation and entrepreneurs building healthcare products.
The EIC Fund is the venture capital investment arm of the European Innovation Council, structured as an investment fund under private law with the European Commission as shareholder. It supplies the equity component of the EIC Accelerator and the STEP Scale Up call, taking minority stakes in European deep-tech companies. The European Investment Bank acts as investment advisor and investor of record, with an external fund manager running the portfolio.
Technology Impact Funds is a fund family managed by Capricorn Investment Group. It invests in companies whose products and services address environmental and social challenges.
NCIC Tech Fund I is the equity vehicle of New Canaan Impact Capital, a merchant bank in Spartanburg, South Carolina that invests directly and syndicates through broker-dealer partner Carofin. The fund backs innovations addressing real-world challenges, with a stated emphasis on intellectual property, and applies an industry-agnostic screen.
Vesalius Biocapital III invests in European life sciences companies developing medicines, medical devices, diagnostics, and digital health technologies. The fund backs science-based innovation and entrepreneurs building healthcare products.
The EIC Fund is the venture capital investment arm of the European Innovation Council, structured as an investment fund under private law with the European Commission as shareholder. It supplies the equity component of the EIC Accelerator and the STEP Scale Up call, taking minority stakes in European deep-tech companies. The European Investment Bank acts as investment advisor and investor of record, with an external fund manager running the portfolio.